U.S. Professional Services Stock News

Why Amdocs Stock Is Back on Investors’ Radar Amdocs (DOX) is drawing fresh investor attention after its stock declined about 21% year to date and about 30% over the past year, even as the company reports revenue and net income growth. At the same time, Amdocs has been winning new large-scale contracts tied to cloud migration, generative AI, and data services, reflecting telecom and media clients’ ongoing digital transformation efforts. See our latest analysis for Amdocs. With the share price...

Q1 results put Chimera Investment (CIM) in focus Chimera Investment (CIM) has moved onto investors’ radar after first quarter 2026 results, where HomeXpress origination volume rose 39% year over year and portfolio shifts toward Agency RMBS were paired with an emphasis on dividend growth. See our latest analysis for Chimera Investment. Following the Q1 update, Chimera Investment’s share price is at $13.28, with a year-to-date share price return of 4.24%. The 1-year total shareholder return of...

Why Dauch Stock Is Back on Investor Radar Dauch (DCH) has been drawing fresh attention after its recent rebrand from American Axle & Manufacturing Holdings, with the stock posting a 22.7% gain over the past month. See our latest analysis for Dauch. While the share price is at US$6.60, the recent 22.7% 30 day share price return contrasts with a more modest 1.7% year to date share price gain and a much stronger 56.0% one year total shareholder return. This points to momentum rebuilding after a...

Advanced Energy Industries recently announced its ADH series of high-efficiency DC-DC converters for 800 V DC AI data center architectures, delivering up to 8 kW peak power and integrating with its NDQ and Hot Swap Control modules to create complete megawatt-capable rack power solutions. This product launch highlights Advanced Energy’s push into higher-power, liquid-cooled AI data center infrastructure, where its compact, scalable converters may help customers increase rack power density and...

Pegasystems stock overview after recent performance shifts Pegasystems (PEGA) has drawn investor attention after a mixed run, with the stock up 0.9% over the past day and 4.7% over the past week, but down over the past month and past 3 months. See our latest analysis for Pegasystems. At a share price of US$35.44, Pegasystems has seen recent short term weakness, with the 30 day share price return down 4.1% and the 90 day share price return down 25.0%. The 3 year total shareholder return of...

Richtech Robotics recently received a Nasdaq notice for missing the filing deadline for its Form 10-Q for the quarter ended March 31, 2026, even as it announced a prospective partnership with SoundHound AI and a new European distribution agreement with NewConsultancy. These developments highlight a company balancing regulatory compliance pressures with efforts to enhance its robots through voice AI and broaden access across the European Union hospitality and service markets. We’ll now...

In late May 2026, The Bancorp, Inc. held its annual meeting, where shareholders elected ten directors, endorsed 2025 executive pay on an advisory basis, and ratified Crowe LLP as the independent auditor for 2026. At the same time, regional lenders like The Bancorp faced fresh scrutiny as inflation-driven expectations of further Federal Reserve rate hikes raised questions about the resilience of their credit-dependent business models. With rising rate expectations pressuring regional lenders’...

Conference spotlight and clinical data as drivers Protagonist Therapeutics (PTGX) is back in focus after highlighting new rusfertide data in polycythemia vera ahead of a major hematology congress, alongside Icotyde’s regulatory approval and early feedback on commercial prospects. See our latest analysis for Protagonist Therapeutics. The share price has reacted strongly to this stream of clinical and conference news, with a 1-day share price return of 7.74% pushing the stock to US$102.79. This...

W.W. Grainger (GWW) has climbed to yearly-high share levels, with investors seemingly focused on expectations for strong earnings growth rather than any major deals, insider buying, or other one off corporate events. See our latest analysis for W.W. Grainger. At a share price of $1,289.37, Grainger has seen strong short term momentum, with a 30 day share price return of 13.62% building on a 28.45% year to date share price gain. The 5 year total shareholder return of 195.34% highlights how...

CRISPR Therapeutics (CRSP) has been back in focus after its stock moved higher on continued progress across its gene editing pipeline, including the commercial rollout of Casgevy and updates on newer programs. See our latest analysis for CRISPR Therapeutics. CRISPR Therapeutics’ recent 9.35% 1 day share price return and 8.72% 30 day share price return, taking the stock to US$56.95, reflects renewed interest following Casgevy’s rollout and fresh updates across its gene editing programs. A...

National HealthCare (NHC) has just shifted five skilled nursing facilities from management contracts to full ownership of both operations and real estate, backed by a recently secured term loan and revolving credit facility. See our latest analysis for National HealthCare. The new credit facilities and acquisition of the five skilled nursing facilities come after a period of strong momentum, with a 30 day share price return of 12.55% and a year to date share price return of 44.18%, alongside...

Earlier this week, The Scotts Miracle-Gro Company reaffirmed its full fiscal 2026 guidance, citing roughly 1% year-over-year growth in branded consumer point-of-sale dollars and about 90% of its commodity costs locked in, while also setting August 4, 2026, for its Investor Day focused on mid- to long-term goals. An interesting angle for investors is how this combination of steady consumer demand indicators and pre-secured input costs could underpin the company's confidence in its margin...

Flowers Foods stock performance snapshot Flowers Foods (FLO) has drawn investor attention after an extended period of weaker returns, with the stock down 15% over the past month and 20% over the past 3 months. See our latest analysis for Flowers Foods. At a share price of $7.30, Flowers Foods has seen its 7 day share price return fall 5.2% and its year to date share price return decline 32.3%, while the 1 year total shareholder return is down 52.6%. This points to fading momentum as investors...

In the past week, Robert Half Inc. participated in the 2026 Baird Global Consumer, Technology & Services Conference and saw its shares advance alongside a broad rally in staffing and employment services peers, while its subsidiary Protiviti secured a second U.S. patent for AI-driven automated data set matching technology. This combination of sector-wide optimism and Protiviti’s new AI patent highlights how Robert Half’s consulting and technology capabilities may be increasingly important to...

If you are wondering whether Hewlett Packard Enterprise (HPE) is still reasonably priced after its recent run, you are not alone. This article focuses squarely on what that current valuation might mean for you. HPE's share price recently closed at US$53.69, with returns of 40.5% over 7 days, 78.7% over 30 days, 122.1% year to date, and 209.9% over the last year, which naturally raises questions about growth potential and how risk is being priced in. Recent headlines around HPE have focused...

In early June 2026, Hycroft Mining Holding Corporation released an S-K 1300 Technical Report Summary and Initial Assessment for its Nevada Hycroft Mine, outlining a 51-year operation using pressure oxidation milling and heap leach processing with base case assumptions including US$3,600 per ounce gold and US$48 per ounce silver. The study, prepared by independent engineering firms, details life-of-mine payable production of about 10.42 million ounces of gold and 347.46 million ounces of...

Legend Biotech (LEGN) is back in focus after early Phase 1 results for LB2501, its in vivo CD19/CD20 CAR-T candidate, showed a 100% response rate and favorable safety at the higher dose in difficult to treat lymphoma. See our latest analysis for Legend Biotech. The LB2501 update comes after a strong run in the stock, with a 7 day share price return of 21.02% and a 90 day share price return of 80.28%. However, the 3 year total shareholder return has declined 50.37%, so recent momentum...

In early June 2026, Arch Capital Group Ltd. priced US$600 million of 5.250% senior notes due 2036 and US$1.40 billions of 5.950% senior notes due 2056, while also launching cash tender offers of up to US$350 million to refinance existing debt and shifting to a single President model under Maamoun Rajeh following David Gansberg’s departure. The decision to expand Rajeh’s remit across insurance, reinsurance, and mortgage alongside large-scale debt issuance highlights Arch Capital’s focus on...

Recent analyst coverage of Ouster (OUST) has converged around a single theme: how its lidar and stereoscopic camera platform is gaining traction across real world automation, robotics, and smart infrastructure applications. See our latest analysis for Ouster. The stock’s recent client announcements with FieldAI and ARGUS, together with the launch of Rev8 and the Stereolabs acquisition, sit against strong momentum, with a 30 day share price return of 64.65% and a 1 year total shareholder...

In late May 2026, Molson Coors Beverage Company announced its third collaboration with Kontoor Brands’ Wrangler label, releasing a limited-edition Coors Banquet x Wrangler festival collection that includes jackets, tees, hats and 250 “Beer Chords” jeans printed with chords from Chase Rice’s new single using beer-based ink. This unconventional use of beer-based ink and music integration underscores how Kontoor is experimenting with culturally resonant, scarcity-driven collaborations to keep...

Why new obicetrapib data matters for NewAmsterdam Pharma (NAMS) NewAmsterdam Pharma (NasdaqGM:NAMS) is back in focus after announcing upcoming presentations of new safety and efficacy data for its oral hypercholesterolemia therapy, obicetrapib, at a major scientific conference. For investors, these data updates offer another reference point on how the company’s late stage pipeline is progressing within cardiometabolic disease, an area where many patients still face limited or hard to tolerate...

What recent returns signal about Revvity stock Without a specific headline event setting the tone, Revvity (RVTY) has drawn investor attention through its recent performance, with the stock showing positive returns over the past week, month, and past 3 months. Over the past week, Revvity is up about 1.2%, adding to an advance of roughly 10.9% over the past month and 12.1% over the past 3 months. For context, the stock’s 1 year total return sits near 13.5%, while the 3 year and 5 year total...

MetLife stock performance snapshot MetLife (MET) has drawn investor attention after recent price moves, with the stock last closing at $83.46. The company reports annual revenue of $77.58b and net income of $3.43b, supported by multiple global business segments. See our latest analysis for MetLife. Recent trading has been firm, with a 1 day share price return of 3.09% and a 90 day share price return of 16.19%. The 5 year total shareholder return of 52.11% points to momentum that has built...

Vertiv Holdings Co (NYSE:VRT) has launched PurgeRite NearZero, a fluid management service for data centers focused on sharply reducing water use. The service targets AI and high density deployments, aiming to improve system cleanliness and support environmental and regulatory priorities. PurgeRite NearZero expands Vertiv's specialized critical infrastructure services portfolio with an ESG oriented offering for data center operators. Vertiv's launch of PurgeRite NearZero comes at a time when...